Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bahaa Abu-Raya

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|February 9, 2024
The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysisEve Nakabembe, Jo Cooper, Kyle Amaral, et al.
Vaccine|June 24, 2022
Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approachesKirsten Maertens, Elke Leuridan, Flor M Munoz, et al.
The Journal of Infectious Diseases|March 18, 2025
Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus InfectionsFrederic Reicherz, Marina Viñeta Paramo, Jeffrey N Bone, et al.
Vaccines|January 8, 2025
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive OptionsMatteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Journal of the Pediatric Infectious Diseases Society|November 10, 2023
Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation MeasuresBahaa Abu-Raya, Frederic Reicherz, Christina Michalski, et al.
Vaccines|August 28, 2025
Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. <i>Vaccines</i> 2024, <i>12</i>, 1317Matteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Journal of the Pediatric Infectious Diseases Society|October 24, 2019
Measles Maternal Antibodies With Low Avidity Do Not Interfere With the Establishment of Robust Quantity and Quality Antibody Responses After the Primary Dose of Measles, Mumps, and Rubella Vaccine Administered at 12-Months of AgeCathleen A Collins, Laura Gelinas, Linda L Yasukawa, et al.
Frontiers in Immunology|August 30, 2021
Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White PaperSusanna Esposito, Bahaa Abu-Raya, Paolo Bonanni, et al.
Iscience|March 23, 2026
HKU1 immune imprinting is associated with post-COVID symptoms after SARS-CoV-2 infectionAbdelilah Majdoubi, Christina Michalski, Allison W Watts, et al.
Frontiers in Immunology|July 26, 2021
The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-AnalysisBahaa Abu-Raya, Kirsten Maertens, Flor M Munoz, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|February 9, 2024
The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysisEve Nakabembe, Jo Cooper, Kyle Amaral, et al.
Vaccine|June 24, 2022
Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approachesKirsten Maertens, Elke Leuridan, Flor M Munoz, et al.
The Journal of Infectious Diseases|March 18, 2025
Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus InfectionsFrederic Reicherz, Marina Viñeta Paramo, Jeffrey N Bone, et al.
Vaccines|January 8, 2025
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive OptionsMatteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Journal of the Pediatric Infectious Diseases Society|November 10, 2023
Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation MeasuresBahaa Abu-Raya, Frederic Reicherz, Christina Michalski, et al.
Vaccines|August 28, 2025
Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. <i>Vaccines</i> 2024, <i>12</i>, 1317Matteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Journal of the Pediatric Infectious Diseases Society|October 24, 2019
Measles Maternal Antibodies With Low Avidity Do Not Interfere With the Establishment of Robust Quantity and Quality Antibody Responses After the Primary Dose of Measles, Mumps, and Rubella Vaccine Administered at 12-Months of AgeCathleen A Collins, Laura Gelinas, Linda L Yasukawa, et al.
Frontiers in Immunology|August 30, 2021
Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White PaperSusanna Esposito, Bahaa Abu-Raya, Paolo Bonanni, et al.
Iscience|March 23, 2026
HKU1 immune imprinting is associated with post-COVID symptoms after SARS-CoV-2 infectionAbdelilah Majdoubi, Christina Michalski, Allison W Watts, et al.
Frontiers in Immunology|July 26, 2021
The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-AnalysisBahaa Abu-Raya, Kirsten Maertens, Flor M Munoz, et al.
Pageof 8